Viewing Study NCT03512756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-05 @ 2:37 AM
Study NCT ID: NCT03512756
Status: TERMINATED
Last Update Posted: 2024-11-06
First Post: 2018-04-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Sponsor: Tyme, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancreatic cancer View
None Pancreas cancer View
None Pancreatic View
None Pancreas View
None cancer View
None low toxicity View
None chemotherapy View
None metastatic View
None SM-88 View
None SM88 View
None 3rd line View
None third line View
None CMBT View
None well tolerated View
None MPS View
None Racemetyrosine View
None Methoxsalen View
None Sirolimus View
None Phenytoin View